Clinical Pharmacokinetics of Lansoprazole (original) (raw)
Barradell LB, Faulds D, McTavish D. Lansoprazole: a review of its pharmacodynamic and pharmacokinetic properties and its therapeutic efficacy in acid-related disorders. Drugs 1992; 44(2): 225–50 ArticlePubMedCAS Google Scholar
Nagaya H, Inatomi N, Satoh H. Effect of repeated administration of AG-1749 (lansoprazole) on acid secretion, serum gastrin level and pharmacokinetics of AG-1749 in Heidenhain Pouch Dogs. Jpn Pharmacol Ther 1991; 19(2): 99–103 Google Scholar
Aoki I, Okumura M, Yashiki T. High-performance liquid chromatographic determination of lansoprazole and its metabolites in human serum and urine. J Chromatogr Biomed Appl 1991; 571(1–2): 283–90 CAS Google Scholar
Delhotal Landes B, Miscoria G, Flouvat B. Determination of lansoprazole and its metabolites in plasma by high-performance liquid chromatography. J Chromatogr 1992; 577: 117–22 Article Google Scholar
Hussein Z, Granneman GR, Mukherjee D, et al. Age-related differences in the pharmacokinetics and pharmacodynamics of lansoprazole. Br J Clin Pharmacol 1993; 36: 391–8 ArticlePubMedCAS Google Scholar
Tateno M, Nakamura N. Phase I study of lansoprazole (AG-1749) antiulcer agent: capsule form. Rinsho Iyaku 1991; 7: 51–62 Google Scholar
Flouvat B, Delhotal Landes B, Dellatolas F, et al. Pharmacocinétique du Lansoprazole ou AG-1749 ou RU 49749 chez le sujet sain. Symposium LANZOR, 1991 Apr 12; Paris
Delhotal Landes B, Cournot A, Vermerie N, et al. The effect of food and antacids on lansoprazole absorption and disposition. Eur J Drug Metab Pharmacokinet 1991; Special issue no. III: 315–20 Google Scholar
Flouvat B, Delhotal Landes B, Cournot A, et al. Single and multiple dose pharmacokinetics of lansoprazole in elderly subjects. Br J Clin Pharmacol 1993; 36: 467–9 ArticlePubMedCAS Google Scholar
Hogan DL, Koss MA, Peitelberg S, et al. Single and repetitive administration of lansoprazole effects on gastric acid secretion, pharmacokinetics and serum gastrin in old vs young subjects [abstract]. Gastroenterology 1991; 100 (5 Pt 2): A84 Google Scholar
Hongo M, Ohara S, Hirasawa Y, et al. Effect of lansoprazole on intragastric pH comparison between morning dosing and evening dosing [abstract]. Gastroenterology 1992; 102 (4 Pt 2): A84 Google Scholar
Moules I, Garrett A, Blockleband D, et al. Gastric acid inhibition by the proton pump inhibitor lansoprazole is unaffected by food. Br J Clin Res 1993; 4: 153–61 Google Scholar
Chassard D, Schlander M, Douin MJ, et al. Study of tolerance, pharmacokinetics and pharmacodynamics of single rising intravenous doses of lansoprazole [abstract]. Eur J Drug Metab Pharmacokinet 1993; 18(1): 109 Google Scholar
Nagaya H, Satoh H, Maki Y. Possible mechanism for the inhibition of acid formation by the proton pump inhibitor AG-1749 in isolated canine parietal cells. J Pharmacol Exp Ther 1990 Mar; 252(3): 1289–95 PubMedCAS Google Scholar
Delhotal Landes B, Flouvat B, Duchier J, et al. Pharmacokinetics of lansoprazole in patients with renal or liver disease of varying severity. Eur J Clin Pharmacol 1993; 45: 367–71 ArticlePubMedCAS Google Scholar
Pichard L, Curi-Pedrosa R, Bonfils C, et al. Oxidative metabolism of lansoprazole by human liver cytochrome P450S. Mol Pharmacol 1995; 47: 410–8 PubMedCAS Google Scholar
Coste T, Logeais C, Delhotal Landes B, et al. Pharmacokinetics of lansoprazole after repeated administration in cirrhosis patients [abstract]. Gastroenterology 1993; 104 (4 Pt 2): A59 Google Scholar
Braeckman RA, Winters EP, Cohen A, et al. Lack of effect of lansoprazole on warfarin pharmacokinetics and anticoagulation effect in healthy subjects. Pharm Res 1991; 8 (10 Suppl.); S295 Google Scholar
Cavanaugh JH, Winters EP, Cohen A, et al. Lack of effect of lansoprazole on steady state warfarin metabolism [abstract]. Gastroenterology 1991; 100 (5 Pt 2): A40 Google Scholar
Cavanaugh JH, Locke C, Karol M. Lack of interaction of lansoprazole or omeprazole with prednisone [abstract]. Am J Gastroenterol 1993; 88(9): 1589 Google Scholar
Granneman G, Winters EP, Locke CS, et al. Lack of effect of concomitant lansoprazole on steady state theophylline pharmacokinetics [abstract]. Gastroenterology 1991; 100 (5 Pt 5): A75 Google Scholar
Roux A, Naline R, Molinier P, et al. Effect of lansoprazole and omeprazole on the metabolism of theophylline and antipyrine in man [abstract]. Eur J Drug Metab Pharmacokinet 1993; 18(1): 125 Google Scholar
Cavanaugh JH, Park YK, Awnin MM, et al. Effect of lansoprazole on antipyrine and IBG pharmacokinetics [abstract]. Gastroenterology 1991; 100 (5 Pt 2): A40 Google Scholar
Lefebvre RA, Flouvat B, Karolak Tamisier S, et al. Influence of lansoprazole treatment on diazepam plasma concentrations. Clin Pharmacol Ther 1992; 52(5): 458–63 ArticlePubMedCAS Google Scholar
Gerloff J, Barth H, Mignot A, et al. Does the proton pump inhibitor lansoprazole interact with antacids? Naunyn Schmiedebergs Arch Pharmacol 1993; 347: R31 Google Scholar
Karol M, Mukherji D, Cavanaugh J. Lack of effect of concomitant multi-dose lansoprazole on single-dose phenytoin pharmacokinetics in subjects [abstract]. Gastroenterology 1994; 106(4): A104 Google Scholar
Fuchs W, Sennewld R, Klotz V. Lansoprazole does not affect the bioavailability of oral contraceptives. Br J Clin Pharmacol 1994; 38: 376 ArticlePubMedCAS Google Scholar
Loght H, Andrieu J, Bognel JC, et al. Lansoprazole versus ranitidine dans le traitement des ulcères duodénaux: resultats d’un essai multicentrique controle, randomissé, en double insu sur groupes parallèles. Med Chir Dig 1991; 19: 251–5 Google Scholar
Hawkey CJ, Long RG, Bardhan KD, et al. Improved symptom relief and duodenal ulcer healing with lansoprazole, a new proton pump inhibitor, compared with ranitidine. Gut 1993; 34: 1458–62 ArticlePubMedCAS Google Scholar
Londong W, Barth H, Dammann HG, et al. Dose related healing of duodenal ulcer with the proton pump inhibitor lansoprazole. Aliment Pharmacol Ther 1991; 5: 245–54 ArticlePubMedCAS Google Scholar
Petite JP, Slama JL, Light H, et al. Comparaison du Lansoprazole (30mg) et de 1’Oméprazole (20mg) dans le traitement de l’ulcère duodénal. Gastroenterol Clin Biol 1993; 17: 334–40 PubMedCAS Google Scholar
Louw JA, Van Rensburg C, Simjee AE, et al. Lansoprazole versus omeprazole in duodenal ulcer healing [abstract]. SAMJ 1993; 83: 777 Google Scholar
Colin R, Laffineur G, Lemaire M. Efficacité comparée du Lansoprazole et de la Ranitidine dans le traitement de l’ulcère gastrique en poussée: etude multicentrique en double aveugle [abstract]. Gastroenterol Clin Biol 1993; 17: A218 Google Scholar
Florent Ch, Forestiers S, Joubert-Collin M. Lansoprazole versus omeprazole: efficacy and safety in acute gastric ulcer [abstract]. Gastroenterology 1993; 104 (4 Pt 2): A80 Google Scholar
Petite JP, Salducci J, Evreux M, et al. Lansoprazole versus ranitidine dans le traitement de l’oesophagite peptique [abstract]. Gastroenterol Clin Biol 1990; 14: A108 Google Scholar
Metz D, Pisegna J, Ringham G, et al. Prospective study of efficacy and safety of lansoprazole in Zollinger-Ellison syndrome. Dig Dis Sci 1993; 38: 245–56 ArticlePubMedCAS Google Scholar
Mignon M, Hochlaf S, Forestiers S, et al. Effet dose-reponse du Lansoprazole chez les malades atteints d’un syndrome de Zollinger-Ellison. Gastroenterol Clin Biol 1994; 18: 13–6 ArticlePubMedCAS Google Scholar
Dammann HG, Von Zur Muhlen A, Balks HJ, et al. The effects of lansoprazole, 30 or 60mg daily, on intragastric pH and on endocrine function in healthy volunteers. Aliment Pharmacol Ther 1993; 7: 191–6 ArticlePubMedCAS Google Scholar
Gaetani M, Buratti P, Pasquali R, et al. Chronic oral administration with lansoprazole does not affect gonadotropin pulsatile pattern in healthy males [abstract]. Gastroenterology 1993; 104: A84 Google Scholar
Solcia E, Villani L, Luinetti O, et al. Proton pump inhibitors, enterochromaffin-like cell growth and helicobacter pylori gastritis. Aliment Pharmacol Ther 1993; 7: 25–8 ArticlePubMedCAS Google Scholar
Fried M, Siegrist H, Frei R, et al. Duodenal bacterial overgrowth during treatment in outpatients with omeprazole. Gut 1994; 35: 23–6 ArticlePubMedCAS Google Scholar
Armstrong D, Viani F, Siegrist H, et al. Does omeprazole increase gastric bacterial counts, nitrite or total nitroso compounds in healthy subjects? [abstract] Gastroenterology 1992; 102: A34 Google Scholar